DexCom has significant room to grow in its core market, despite disappointing results last year. One of Warren Buffett's ...

Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...

Wall Street hits record highs as payrolls surge. Explore healthcare stock movers, obesity drug breakthroughs, AbbVie deals, Centene struggles & ...

Overweight and obesity are growing public health challenges in the Philippines. In just over two decades, the prevalence of overweight and obesity among Filipino adults has doubled, rising from 20% in ...

Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.